Study Description

The goal of this study was to identify genetic risk factors for drug-induced prolongation of the QT interval (diLQT) and the... Show More

Study Accession Alternative Stable ID type
phs000331.v1.p1 dbGaP Case-Control

Who controls access to this study

National Heart, Lung, and Blood Institute DAC
Access information: http://grants.nih.gov/grants/gwas

Publications

Data provider(s)

  • Title Name Institute
    Principal Investigator Dan Roden, MD Vanderbilt University Medical Center, Nashville, TN, USA
    Institute Vanderbilt University PGRN Group (PAT) Vanderbilt University Medical Center, Nashville, TN, USA

Who archives the data?

The database of Genotypes and Phenotypes (dbGaP)